• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾衰竭患者不平衡纵向血细胞比容水平演变的混合效应模型。

A mixed-effect model for the evolution of unbalanced longitudinal hematocrit levels in chronic kidney failure patients.

作者信息

Fissuh Yemane Hailu, Nega Getachew Beyene, Hailay Azmera

机构信息

Biostatistics, Department of Statistics, College of Natural and Computational Sciences, Aksum University, Axum, Tigray, Ethiopia.

Department of Statistics, College of Natural and Computational Sciences, Mekelle University, Tigray, Ethiopia.

出版信息

SAGE Open Med. 2025 Sep 13;13:20503121251360864. doi: 10.1177/20503121251360864. eCollection 2025.

DOI:10.1177/20503121251360864
PMID:40955279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12433553/
Abstract

BACKGROUND

Chronic kidney disease, or renal failure, is a public health problem with an estimated prevalence of 8%-16% worldwide. This study was conducted to investigate the evolution of hematocrit levels over time in renal patients after transplantation and to determine how the evolution of hematocrit levels depends on the patients' age, sex, and other factors.

OBJECTIVE

The main objective of this study was to employ a mixed-effects model to examine the unbalanced longitudinal evolution of hematocrit levels in chronic kidney failure patients.

METHODOLOGY

This longitudinal study included 1160 patients who received a renal transplant. These patients were followed for at most 10 years. The hematocrit level was considered the response, while the covariates were time in years, sex, and age of the patients. Different statistical methods, such as explanatory analysis, multivariate regression, two-stage analysis, and linear mixed-effects models, were employed to explore the evolution of hematocrit over time.

RESULTS

The results revealed that hematocrit levels in kidney transplant patients evolve. The sex and age of the patient significantly affect the evolution of hematocrit levels. Males tend to have a greater increase in hematocrit levels over time than females do. Hematocrit levels tend to increase with increasing age. Furthermore, cardiovascular problems before transplant and rejection symptoms did not significantly affect the evolution of hematocrit levels.

CONCLUSIONS

Hematocrit levels evolve, and this evolution follows a quartic time effect. The change in hematocrit levels varies according to the sex and age of the patient after a kidney transplant. Patients with low hematocrit levels tend to have a greater increase over time.

摘要

背景

慢性肾脏病,即肾衰竭,是一个公共卫生问题,据估计全球患病率为8%-16%。本研究旨在调查肾移植患者移植后血细胞比容水平随时间的变化情况,并确定血细胞比容水平的变化如何取决于患者的年龄、性别和其他因素。

目的

本研究的主要目的是采用混合效应模型来检验慢性肾衰竭患者血细胞比容水平的不平衡纵向变化。

方法

这项纵向研究纳入了1160例接受肾移植的患者。这些患者最多随访10年。将血细胞比容水平视为反应变量,而协变量为患者的年龄(以年计)、性别和时间。采用不同的统计方法,如解释性分析、多元回归、两阶段分析和线性混合效应模型,来探讨血细胞比容随时间的变化情况。

结果

结果显示肾移植患者的血细胞比容水平会发生变化。患者的性别和年龄显著影响血细胞比容水平的变化。随着时间的推移,男性的血细胞比容水平往往比女性有更大的升高。血细胞比容水平往往随年龄增长而升高。此外,移植前的心血管问题和排斥症状并未显著影响血细胞比容水平的变化。

结论

血细胞比容水平会发生变化,且这种变化呈现四次时间效应。肾移植后,血细胞比容水平的变化因患者的性别和年龄而异。血细胞比容水平较低的患者随着时间的推移往往有更大的升高幅度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ad/12433553/42a598e8c1ff/10.1177_20503121251360864-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ad/12433553/86e344841352/10.1177_20503121251360864-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ad/12433553/42a598e8c1ff/10.1177_20503121251360864-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ad/12433553/86e344841352/10.1177_20503121251360864-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ad/12433553/42a598e8c1ff/10.1177_20503121251360864-fig6.jpg

相似文献

1
A mixed-effect model for the evolution of unbalanced longitudinal hematocrit levels in chronic kidney failure patients.慢性肾衰竭患者不平衡纵向血细胞比容水平演变的混合效应模型。
SAGE Open Med. 2025 Sep 13;13:20503121251360864. doi: 10.1177/20503121251360864. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
5
Sexual Harassment and Prevention Training性骚扰与预防培训
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
A retrospective multi-site examination of chronic kidney disease using longitudinal laboratory results and metadata to identify clinical and financial risk.一项利用纵向实验室结果和元数据对慢性肾病进行的回顾性多中心检查,以识别临床和财务风险。
BMC Nephrol. 2024 Dec 6;25(1):447. doi: 10.1186/s12882-024-03869-4.
2
An Approach for Personalized Dynamic Assessment of Chronic Kidney Disease Progression Using Joint Model.一种使用联合模型对慢性肾脏病进展进行个性化动态评估的方法。
Biomedicines. 2024 Mar 11;12(3):622. doi: 10.3390/biomedicines12030622.
3
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
慢性肾脏病的心血管并发症:来自欧洲肾脏病协会的欧洲肾脏和心血管医学工作组的综述。
Cardiovasc Res. 2023 Sep 5;119(11):2017-2032. doi: 10.1093/cvr/cvad083.
4
Mixed-effects model: a useful statistical tool for longitudinal and cluster studies.混合效应模型:纵向研究和聚类研究的一种有用统计工具。
J Bras Pneumol. 2023 May 15;49(2):e20230137. doi: 10.36416/1806-3756/e20230137.
5
Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients.血红蛋白与慢性肾脏病进展的关系:日本患者前瞻性队列研究的二次分析。
BMC Nephrol. 2022 Aug 23;23(1):295. doi: 10.1186/s12882-022-02920-6.
6
Prevalence of anemia in predialysis chronic kidney disease: Is the study center a significant factor?透析前慢性肾脏病患者贫血的患病率:研究中心是一个重要因素吗?
PLoS One. 2020 Apr 2;15(4):e0230980. doi: 10.1371/journal.pone.0230980. eCollection 2020.
7
Mixed-effects models for health care longitudinal data with an informative visiting process: A Monte Carlo simulation study.具有信息性就诊过程的医疗保健纵向数据的混合效应模型:一项蒙特卡罗模拟研究。
Stat Neerl. 2020 Feb;74(1):5-23. doi: 10.1111/stan.12188. Epub 2019 Sep 5.
8
Chronic Kidney Disease Diagnosis and Management: A Review.慢性肾脏病的诊断与管理:综述。
JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745.
9
Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease.基于斜率的终点的混合效应模型在慢性肾脏病临床试验中的应用。
Stat Med. 2019 Sep 30;38(22):4218-4239. doi: 10.1002/sim.8282. Epub 2019 Jul 23.
10
Chronic kidney disease: global dimension and perspectives.慢性肾脏病:全球维度与展望。
Lancet. 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X. Epub 2013 May 31.